Pancreatic Cancer Research

ResearcherUniversity of VeronaNo recent work listed

Renzo Mazzarotto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0122-1871; OpenAlex author ID A5049020305. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
35
Papers, trials and grants by year

2020: 4 papers · 2021: 3 papers · 2022: 2 papers · 2023: 1 paper

Papers 10

  1. Comparative Effectiveness of Chemotherapy Alone Versus Radiotherapy-Based Regimens in Locally Advanced Pancreatic Cancer: A Real-World Multicenter Analysis (PA… Co-author DOI 10.3390/curroncol30060427↗
  2. Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm? Co-author DOI 10.3390/life12040465↗
  3. Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy. Last author DOI 10.4251/wjgo.v14.i3.703↗
  4. Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcin… Last author DOI 10.1016/j.clon.2020.06.019↗
  5. A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy i… Co-author DOI 10.1186/s12885-021-07877-7↗
  6. Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer. Last author DOI 10.3389/fonc.2021.662205↗
  7. Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1). Co-author DOI 10.1002/cam4.3330↗
  8. Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1). Co-author DOI 10.21873/anticanres.13975↗
  9. Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to … Co-author DOI 10.3389/fonc.2020.600940↗
  10. Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical … Co-author DOI 10.3390/cancers12071729↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nicola Simoni · 10 shared papers, 2020–2023 · strength 1.11
  2. Gabriella Rossi · 5 shared papers, 2020–2022 · strength 0.61
  3. Francesco Cellini · 5 shared papers, 2020–2023 · strength 0.56
  4. Giuseppe Malleo · 5 shared papers, 2020–2022 · strength 0.55
  5. Claudio Bassi · 5 shared papers, 2020–2022 · strength 0.55
  6. Salvatore Paiella · 5 shared papers, 2020–2022 · strength 0.55
  7. Roberto Salvia · 5 shared papers, 2020–2022 · strength 0.55
  8. Michèle Milella · 4 shared papers, 2020–2021 · strength 0.42
  9. Alessio Giuseppe Morganti · 4 shared papers, 2020–2023 · strength 0.40
  10. Milly Buwenge · 4 shared papers, 2020–2023 · strength 0.40
  11. Alessandra Arcelli · 4 shared papers, 2020–2023 · strength 0.40
  12. Gian Carlo Mattiucci · 3 shared papers, 2020–2023 · strength 0.31
  13. Savino Cilla · 3 shared papers, 2020–2023 · strength 0.30
  14. Gabriella Macchia · 3 shared papers, 2020–2023 · strength 0.30
  15. Mariacristina Di Marco · 3 shared papers, 2020–2023 · strength 0.30
  16. Vincenzo Valentini · 2 shared papers, 2020–2022 · strength 0.25
  17. Tommaso Giuliani · 2 shared papers, 2021 · strength 0.22
  18. Michele Fiore · 2 shared papers, 2020–2023 · strength 0.21
  19. Nunziata D’Abbiero · 1 shared paper, 2022 · strength 0.16
  20. Ester M. Orlandi · 1 shared paper, 2022 · strength 0.16
  21. Viviana Vitolo · 1 shared paper, 2022 · strength 0.16
  22. Lidia Strigari · 1 shared paper, 2023 · strength 0.13
  23. Matteo De Pastena · 1 shared paper, 2021 · strength 0.10
  24. Erica Secchettin · 1 shared paper, 2021 · strength 0.10
  25. Massimiliano Tuveri · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.